RE:RE:RE:Buyout frameworkAlgernon has filed new intellectual property rights globally for NP-120 (ifenprodil) for the treatment of respiratory diseases and is working to develop a proprietary injectable and slow-release formulation.
the drug is from the 1970s, it must be a method of use patent. Very weak and not awarded yet, I hope you make money but don't expect a big pharma buyout from a 5 year old drug and no patent